Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. IDXX

Healthcare  —  Diagnostics & Research
519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
S&P 500 Member Cash Flow Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

 64.63% 66.20% 72.92% 74.21%
ROA 30.50% 31.89% 33.19% 33.65%
ROIC 43.47% 45.33% 48.68% 48.87%
Return on Tangible Assets 106.50% 104.65% 122.43% 119.33%
Average Days of Receivables 49.65 46.85 49.55 50.27
Free Cash Flow per Share 10.78 11.89 13.28 15.67
Free Cash Flow 863.22 956.58 1,058.11 1,237.09
Capital Expenditures (224.85) (225.23) (151.98) (134.42)
Piotroski F-Score 7.00 7.00 7.00 8.00
Other line items
Cash ROIC 47.43% 52.87% 54.84% 60.70%
Accounts Receivable Turnover 7.73 8.39 7.86 7.67
Accounts Payable Turnover 13.70 14.64 13.49 13.92
Inventory Turnover 4.08 4.33 4.34 4.36
Average Days of Payables 27.97 24.51 28.12 27.56
Days of Inventory on Hand 89.59 83.86 82.73 83.59
Tax Rate (0.19) (0.20) (0.20) (0.20)
Research and Development Expense of Revenue 5.81% 5.84% 5.80% 5.74%
Selling, General and Administrative Expense of Revenue 24.57% 24.36% 24.63% 24.67%
Share Based Compensation of Revenue 1.40% 1.39% 1.39% 1.38%
Interest Coverage 0.00 0.00 0.00 0.00
Operating CF/Net income 1.06 1.12 1.10 1.20
Depreciation/Fixed assets 0.19 0.19 0.20 0.21
Capex/Depreciation (1.60) (1.55) (1.02) (0.87)
Revenue per Share 52.03 53.51 55.82 57.67
Operating CF per Share 13.58 14.69 15.19 17.37
Capex per Share (2.81) (2.80) (1.91) (1.70)
Capex to Sales 0.05 0.05 0.03 0.03
Net Profit Margin 24.65% 24.62% 24.63% 25.03%

Fold the line items

Columns are period end dates